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Background: The angiographic features of restenosis have significant prognostic information. However, restenosis patterns of the new generation 
drug-eluting stent (DES), everolimus- (EES) and Resolute zotarolimus-eluting stents (ZES), have not been described yet. In this study, we analyzed the 
angiographic patterns of restenosis that occurred after DES implantation, and compared the morphologic characteristics of the 2nd generation DES 
restenosis to those of the 1st generation DES, sirolimus- (SES) and paclitaxel-eluting stents (PES), restenosis.
Methods: We identified 208 episodes of restenosis (103 for PES, 72 for SES, 13 for EES, and 20 for ZES) after DES implantation in our institution 
between May 2003 and December 2010. Restenosis pattern was classified as focal, diffuse, proliferative, or occlusive. The position of focal 
restenosis was further categorized as articulation, edge, body, or multi-focal.
Results: The incidence of focal restenosis was significantly lower in the PES than in other stents (50.5% vs. 84.7%, 84.6%, and 85.0% for PES vs. 
SES, EES, and ZES, respectively, p<.001), and consequently focal restenosis was more common in the 2nd generation DES than in the 1st generation 
DES (84.8% vs. 64.6%, p=.023). When considering the restenosis solely within the stent margins, the incidence of diffuse intra-stent restenosis was 
much lower in the 2nd generation DES than the 1st generation DES (5.6% vs. 40.0%, p=.005). There were no significant differences in the position 
of focal restenosis among stents, and the proportion of edge restenosis in the 2nd generation DES was not significantly different from that of the 1st 
generation DES (28.6% vs. 32.7%, p=.673).
Conclusions: Focal restenosis was the most common pattern of restenosis in the 2nd generation DES, and diffuse intra-stent restenosis was 
notably decreased in the 2nd generation DES era. However, there was no chronological change in the proportion of edge restenosis.
